Aktuelle Ernährungsmedizin 2013; 38(06): 418-423
DOI: 10.1055/s-0033-1349670
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Auswirkungen kohlenhydratreduzierter und kohlenhydratmodifizierter Diäten auf kardiovaskuläre Biomarker

Comparison of Effects of Carbohydrate Restricted and Carbohydrate Modified Diets on Cardiovascular Biomarkers
L. Schwingshackl
Universität Wien, Fakultät für Lebenswissenschaften, Department für Ernährungswissenschaften
,
G. Hoffmann
Universität Wien, Fakultät für Lebenswissenschaften, Department für Ernährungswissenschaften
› Author Affiliations
Further Information

Publication History

Publication Date:
04 December 2013 (online)

Zusammenfassung

Zahlreiche randomisiert-kontrollierte Studien (RCTs) kommen zu dem Schluss, das kohlenhydratreduzierte (low carb, LC) Diäten in der Kontrolle kardiovaskulärer Risikofaktoren mindestens so effektiv sind wie fettreduzierte (low fat, LF) Kostformen. Für die vorliegende Übersichtsarbeit wurde in der Datenbank MEDLINE nach Metaanalysen von RCTs mit folgenden Stichwörtern gesucht: „low carbohydrate diet“ und „glycemic index diet“. Insgesamt konnten 17 Metaanalysen inkludiert werden. Im Großteil der Studien wurden signifikante Vorteile der LC- bzw. kohlenhydratmodifizierten Diäten gegenüber den LF-Diäten im Hinblick auf die Veränderung kardiovaskulärer Biomarker/Risikofaktoren wie HDL-Cholesterin, Triglyzeride, Nüchternglukose, Nüchterninsulin und glykosyliertes Hämoglobin beobachtet. Teilweise wurde allerdings von erhöhten Gesamt- und LDL-Cholesterinwerten in den LC-Gruppen berichtet, was u. a. auf eine erhöhte Zufuhr an gesättigten Fettsäuren zurückgeführt werden kann. Durch eine anteilsmäßige Erhöhung der Zufuhr an einfach und mehrfach ungesättigten Fettsäuren könnte diesen negativen Auswirkungen vorgebeugt werden. Die amerikanische Diabetesgesellschaft hat 2008 die LC-Diät offiziell in ihre Empfehlungen mitaufgenommen. Es bleibt abzuwarten, ob weitere Fachgesellschaften folgen, und ob möglicherweise auch der damit eng assoziierte glykämische Index in neuen Empfehlungen Platz finden wird. Die Evidenz aus Metaanalysen folgend kann es als wahrscheinlich angesehen werden, dass eine Kohlenhydratmodifikation protektive Effekte in der Primärprävention ernährungsabhängiger Krankheiten ausübt.

Abstract

Numerous randomized controlled trials (RCTs) concluded that low carbohydrate (LC) diets are at least as effective as low fat (LF) diets with respect to their beneficial impact on biomarkers and risk factors of cardiovascular diseases and other nutrition-related disorders. For this review, a literature query for meta-analyses of RCTs was performed using the electronic database MEDLINE using the following search terms: “low carbohydrate diet” and “low glycemic index diet”. A total of 17 meta-analyses could be included in this report. In most of these, improvements in cardiovascular risk factors, i. e. HDL-cholesterol, triacylglycerols, fasting glucose, fasting insulin and glycosylated hemoglobin turned out to be more pronounced following LC/low glycemic index diets as compared to LF/high glycemic index protocols. However, this was sometimes associated with a detrimental variation in total and LDL-cholesterol, possibly due to the high amount of saturated fat consumed by the LC groups. It seems reasonable to speculate that by increasing the amount of monounsaturated and polyunsaturated fats in the diet, these adverse effects might be avoided. In 2008, the American Diabetes Association incorporated LC diets into their official recommendations. It remains to be seen whether other international authorities will include LC regimens and the associated glycemic index in their recommendations as well. The present summary of meta-analyses provides probable evidence that carbohydrate modified diets have beneficial effects in the primary prevention of non-communicable diseases.

 
  • Literatur

  • 1 WHO. Obesity and Overweight. 2011. Fact sheet No. 311. http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed: 20.10.2013)
  • 2 Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: iii-iv, 1-182
  • 3 Astrup A, Meinert Larsen T, Harper A. Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss?. Lancet 2004; 364: 897-899
  • 4 Krauss RM, Eckel RH, Howard B et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 2000; 31: 2751-2766
  • 5 Zello GA. Dietary Reference Intakes for the macronutrients and energy: considerations for physical activity. Appl Physiol Nutr Metab 2006; 31: 74-79
  • 6 Atkins RC, Ornish D, Wadden T. Low-carb, low-fat diet gurus face off. Interview by Joan Stephenson. JAMA 2003; 289: 1767-1768, 1773
  • 7 DGE. Kohlenhydratzufuhr und Prävention ausgewählter ernährungsmitbedingter Krankheiten – Evidenzbasierte Leitlinie. Bonn: 2011
  • 8 Food and Nutrition Board IoM. Dietary reference intakes for energy, carbohydrates, fiber, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington: DNAP ed; 2002: 207-264
  • 9 Lichtenstein AH, Appel LJ, Brands M et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96
  • 10 Kris-Etherton PM, Innis S. American Dietetic Association. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007; 107: 1599-1611
  • 11 EFSA. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal 2010; 8: 1461 (1107pp.)
  • 12 Bravata DM, Sanders L, Huang J et al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003; 289: 1837-1850
  • 13 Nordmann AJ, Nordmann A, Briel M et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285-293
  • 14 Hession M, Rolland C, Kulkarni U et al. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev 2009; 10: 36-50
  • 15 Hu T, Mills KT, Yao L et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2012; 176 (Suppl. 07) S44-54
  • 16 Santos FL, Esteves SS, da Costa Pereira A et al. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev 2012; DOI: DOI: 10.1111/j.1467-789X.2012.01021.x.
  • 17 Bueno NB, de Melo IS, de Oliveira SL et al. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr 2013; DOI: 1-10 DOI: 10.1017/S0007114513000548.
  • 18 Cao Y, Mauger DT, Pelkman CL et al. Effects of moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a meta-analysis of clinical trials in subjects with and without diabetes. J Clin Lipidol 2009; 3: 19-32
  • 19 Kirk JK, Graves DE, Craven TE et al. Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. J Am Diet Assoc 2008; 108: 91-100
  • 20 Kodama S, Saito K, Tanaka S et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care 2009; 32: 959-965
  • 21 Siri-Tarino PW, Sun Q, Hu FB et al. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010; 91: 502-509
  • 22 Siri-Tarino PW, Sun Q, Hu FB et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91: 535-546
  • 23 Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009; 55: 173-201
  • 24 Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7: e1000252
  • 25 Jakobsen MU, O'Reilly EJ, Heitmann BL et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89: 1425-1432
  • 26 Jakobsen MU, Dethlefsen C, Joensen AM et al. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010; 91: 1764-1768
  • 27 Mensink RP, Zock PL, Kester AD et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155
  • 28 Schwingshackl L, Strasser B. High-MUFA diets reduce fasting glucose in patients with type 2 diabetes. Ann Nutr Metab 2012; 60: 33-34
  • 29 Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab 2011; 58: 290-296
  • 30 Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010; 91: 46-63
  • 31 Otto H, Bleyer G, Pennartz M et al. Kohlenhydrataustausch nach biologischen Äquivalenten. Bern: Hans Huber; 1973
  • 32 Jenkins DJ, Wolever TM, Taylor RH et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362-366
  • 33 Brand-Miller J, Hayne S, Petocz P et al. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003; 26: 2261-2267
  • 34 Thomas D, Elliott EJ. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst Rev 2009; DOI: DOI: 10.1002/14651858.CD006296.pub2. CD006296
  • 35 Livesey G, Taylor R, Hulshof T et al. Glycemic response and health – a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 2008; 87: 258S-268S
  • 36 Opperman AM, Venter CS, Oosthuizen W et al. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004; 92: 367-381
  • 37 Thomas DE, Elliott EJ, Baur L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst Rev 2007; DOI: DOI: 10.1002/14651858.CD005105.pub2. CD005105
  • 38 Goff LM, Cowland DE, Hooper L et al. Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2012; DOI: DOI: 10.1016/j.numecd.2012.06.002.
  • 39 Kelly S, Frost G, Whittaker V et al. Low glycaemic index diets for coronary heart disease. Cochrane Database Syst Rev 2004; DOI: DOI: 10.1002/14651858.CD004467.pub2. CD004467
  • 40 Dong JY, Zhang L, Zhang YH et al. Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Br J Nutr 2011; 106: 1649-1654
  • 41 Mente A, de Koning L, Shannon HS et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169: 659-669
  • 42 Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2013; DOI: DOI: 10.1016/j.numecd.2013.04.008.
  • 43 Frank H, Graf J, Amann-Gassner U et al. Effect of short-term high-protein compared with normal-protein diets on renal hemodynamics and associated variables in healthy young men. Am J Clin Nutr 2009; 90: 1509-1516
  • 44 Larsen RN, Mann NJ, Maclean E et al. The effect of high-protein, low-carbohydrate diets in the treatment of type 2 diabetes: a 12 month randomised controlled trial. Diabetologia 2011; 54: 731-740
  • 45 Krebs JD, Elley CR, Parry-Strong A et al. The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia 2012; 55: 905-914
  • 46 Friedman AN, Ogden LG, Foster GD et al. Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol 2012; 7: 1103-1111
  • 47 Bernstein AM, Sun Q, Hu FB et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation 2010; 122: 876-883
  • 48 Fung TT, van Dam RM, Hankinson SE et al. Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med 2010; 153: 289-298
  • 49 Lagiou P, Sandin S, Weiderpass E et al. Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med 2007; 261: 366-374
  • 50 Trichopoulou A, Psaltopoulou T, Orfanos P et al. Low-carbohydrate-high-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr 2007; 61: 575-581
  • 51 Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320-328
  • 52 Hooper L, Abdelhamid A, Moore HJ et al. Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ 2012; 345: e7666
  • 53 Bantle JP, Wylie-Rosett J, Albright AL et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31 (Suppl. 01) S61-78
  • 54 Linsel-Nitschke P, Gotz A, Erdmann J et al. Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease – a Mendelian Randomisation study. PLoS One 2008; 3: e2986